Live Help
Want to know more
Enter the details and we'll call you soon

Name :

Company Name :

City :

Mobile No. :

Email id :


Thank you for your details

Our Executive will reach you shortly.

Your Session Will Expire in   seconds.
If you do not wish to log-out, choose 'Let me continue'
Reset SessionCancel Session

Non-supply of products by co. on account of inability to produce NOC is an anti-competitive practice

June 6, 2019[2019] 106 40 (CCI)

Competition Act : Non-supply of pharmaceutical products by pharmaceutical companies to applicant stockist on account of inability to produce NOC/LOC from State and regional chemists and druggist associations aptly establishes agreement/arrangement/understanding between these pharmaceutical companies and trade associations, in contravention of provisions of section 3(1). Accordingly office bearers of contravening associations and officials of contravening pharmaceutical companies were to cease and desist from indulging in practice of mandating clearance/NOC/LOC and penalty was to be imposed upon them

read more
Best view in 1140 x 768